
DermaPrecise is an electronic multi-needle dermal injector to be used when consistent precision over depth, dose, and delivery matters. Owned by @RepliCel.
Joined October 2021
- Tweets15
- Following69
- Followers42
- Likes31
DermaPrecise retweeted
Hair loss is one of the most common conditions that dermatologists. Learn more:
bit.ly/3x66KQF #HairLossAwarenessMonth
DermaPrecise retweeted
Independent Laboratory Test Results Confirm Value of DermaPrecise (TM) Injection Consistency in Clinical Simulation Testing. accesswire.com/709732/Indepe… #dermtwitter #dermatology #dermalinjections #hairloss
DermaPrecise retweeted
The #eczema pipeline includes a number of biologic agents that target novel cytokines—IL-13 and IL-31. Watch April Armstrong, MD, MPH, discuss the evidence in this video: okt.to/70wXqF
#dermtwitter #dermatology
DermaPrecise retweeted
The extracellular matrix under skin loses ~1% of its collagen per year. By age 45, we face ~25% collagen loss causing a loss of skin support structure and elasticity. RCS-01 is in development to stimulate new collagen production using a patient's own cells. #naturalregeneration
DermaPrecise retweeted
Very interesting article. There are so many variables with the MN and/or PRP techniques for hair loss. I do agree, a further research is needed. Thx for sharing.
A systematic review of microneedling for #hairloss - either standalone or in combination with other treatments like PRP. 22 clinical studies with 1127 subjects were evaluated. Hair parameters improved for a range of hair loss types. #openaccess
doi.org/10.1007/s13555-021-0…
DermaPrecise retweeted
Prior to his session at Dermatology Week, Dr Hassan Galadari discussed updates in neuromodulators and injectable fillers including considerations on how to go about the procedures. Watch his discussion here: okt.to/eirFut
#dermtwitter #cosmetic #dermatology
DermaPrecise retweeted
Replying to @najla_aldawsari
FDA In Brief: FDA Warns Public and Health Care Professionals Not to Use Needle-free Devices for Injection of Dermal Fillers
fda.gov/news-events/press-an…








